A
Anne Krivine
Researcher at Paris Descartes University
Publications - 38
Citations - 1294
Anne Krivine is an academic researcher from Paris Descartes University. The author has contributed to research in topics: Vaccination & Seroconversion. The author has an hindex of 23, co-authored 38 publications receiving 1174 citations.
Papers
More filters
Journal ArticleDOI
Protective effect of A/H1N1 vaccination in immune-mediated disease—a prospectively controlled vaccination study
Sabine Adler,Anne Krivine,Janine Weix,Flore Rozenberg,Odile Launay,Juerg Huesler,Loïc Guillevin,Peter M. Villiger +7 more
TL;DR: The results show that vaccination response is a function of disease type, intensity and character of medication and age, and a single injection of adjuvanted A/H1N1 influenza vaccine is sufficient to protect a high percentage of patients.
Journal ArticleDOI
Population Pharmacokinetics of Tenofovir in Human Immunodeficiency Virus-Infected Patients Taking Highly Active Antiretroviral Therapy
Vincent Jullien,Jean-Marc Tréluyer,Elisabeth Rey,Patrick Jaffray,Anne Krivine,Laurence Moachon,Agnès Lillo-Le Louët,Anne Lescoat,Nicolas Dupin,Dominique Salmon,Gérard Pons,Saïk Urien +11 more
TL;DR: The influence of renal function on tenofovir pharmacokinetics was investigated in 193 human immunodeficiency virus (HIV)-infected patients by the use of a population approach performed with the nonlinear mixed effects modeling program NONMEM.
Journal ArticleDOI
Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission.
Constance Delaugerre,Laurence Morand-Joubert,Marie-Laure Chaix,Odile Picard,Anne-Geneviève Marcelin,Véronique Schneider,Anne Krivine,Alexandra Compagnucci,Christine Katlama,Pierre-Marie Girard,Vincent Calvez +10 more
TL;DR: The results suggest that it is highly difficult to return to a wild-type viral population, sensitive to an antiretroviral treatment, after 2 years of follow-up in HIV-1-infected patients.
Journal ArticleDOI
Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France
Diane Descamps,Marie-Laure Chaix,Brigitte Montes,Sophie Pakianather,Charlotte Charpentier,Alexandre Storto,Francis Barin,Georges Dos Santos,Anne Krivine,Constance Delaugerre,Jacques Izopet,Anne-Geneviève Marcelin,Anne Maillard,Laurence Morand-Joubert,Coralie Pallier,Jean-Christophe Plantier,Catherine Tamalet,Jacqueline Cottalorda,Delphine Desbois,Vincent Calvez,Françoise Brun-Vézinet,Bernard Masquelier,Dominique Costagliola,Chakib Alloui,D. Bettinger,G. Anies,B. Masquelier,S. Vallet,Cécile Henquell,M. Bouvier-Alias,G. DosSantos,Anne Signori-Schmuck,S. Rogez,Patrice Andre,Jean-Claude Tardy,Mary-Anne Trabaud,C. Tamalet,B. Montes,J. Cottalorda,Diane Descamps,F. Brun-Vézinet,C. Charpentier,Marie Laure Chaix,D. Desbois,Slim Fourati,A. G. Marcelin,V. Calvez,Philippe Flandre,L. Morand-Joubert,C. Delaugerre,Annick Ruffault,A. Maillard,J. C. Plantier,Thomas Bourlet,Henia Saoudin,J. Izopet,F. Barin +56 more
TL;DR: In France in 2006/2007, the prevalence of transmitted drug-resistant variants was 10.6%, comparable in B and non-B subtypes and prevalence of non- B subtypes is still rising.
Journal ArticleDOI
Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study.
Odile Launay,Sophie Grabar,Emmanuel Gordien,Corinne Desaint,David Jegou,Sébastien Abad,Pierre-Marie Girard,Linda Belarbi,Corinne Guérin,Jérôme Dimet,V. Williams,Anne Krivine,Dominique Salmon,Olivier Lortholary,David Rey +14 more
TL;DR: In HIV-infected adults, immunogenicity of hepatitis A vaccine is poor and three doses of vaccine were safe and increased antibody titers.